Introduction
Plasmid mediated production of penicillinase by strains of Neisseria gonorrhoeae (PPNG strains) has become common throughout the world; chromosomally mediated resistance to penicillin is also increasing.' A survey in Bangkok in 1978 showed that PPNG strains caused 8 6% of all gonococcal infections.2 Recently PPNG strains caused more than 400/ of gonococcal infections in Bangkok3 and more than 10% in other Thai cities (Thai Venereal Disease Division, quarterly reports 1980-3, unpublished). MICs of penicillin 21 mg/l were also found against more than half the non-PPNG strains in Bangkok. 3 Although gonococci resistant to penicillin are much less common in the United States, where PPNG strains account for less than 0-5% of all gonococcal infections, a prevalence of more than 5% has been noted in three major metropolitan areas. 4 Gonococci that are chromosomally resistant to penicillin have been identified in several outbreaks in the United States. 5 6 A single 2 g dose of spectinomycin has been proved to be a safe and effective treatment of infections with gonococci that are resistant or susceptible to penicillin. Gonococci resistant to both penicillin and spectinomycin, however, have recently been identified in sporadic cases in several countries and in a small epidemic. 7 The gonococcus continues to exhibit the ability to develop resistance to antimicrobials, which necessitates the evaluation of new therapeutic agents to treat gonorrhoea.
Cefuroxime appears to be safe and effective in treating uncomplicated gonococcal infections. 8 At the return visit we re-examined patients, confirmed their histories, and took further material for culture of N gonorrhoeae from the same anatomical sites as at the first visit. Side effects were identified by asking each patient whether they had experienced pain at the injection site, diarrhoea, nausea, vomiting, rash, itching, or other problems. Injection pain was considered to be important only if the pain lasted several hours. LABORATORY 
METHODS
All specimens were immediately inoculated on to modified Thayer-Martin medium, placed in candle extinction jars, and incubated at 35-360C within one hour. Typical Gram negative diplococci in oxidase reactive colonies growing on selective medium were presumptively identified as N gonorrhoeae. The identity of these isolates was confirmed using the rapid sugar utilisation technique. 18 Isolates were tested for penicillinase production using the starch paper method. '9 Gonococcal isolates were suspended in trypticase soy broth with glycerol and stored at -700C. Frozen isolates were shipped to the Centers for Disease Control (CDC), Atlanta, Georgia, USA, where their identities were reconfirmed.3 Agar plate dilution tests were used to measure the minimum inhibitory concentrations (MICs) of 11 antibiotics against each isolate. The ranges of concentrations of antimicrobials tested were: penicillin G 0 004 to 64 mg/l, cefuroxime 0 015 to 2 mg/l, cefoxitin 0 06 to 8 mg/l, cefotaxime 0 002 to 0 5 mg/l, tetracycline 0 06 to 8 mg/l, erythromycin 0'015 to 2 mg/l, spectinomycin 2 to 256 mg/l, kanamycin 0*125 to 64 mg/l, thiamphenicol 0 125 to 8 mg/l, and trimethoprim-sulphamethoxazole 0 03 and 0-6 to 2 and 38 mg/l.
ANALYSIS OF DATA
Only patients with a positive culture for N gonorrhoeae on the day of treatment and who returned for re-evaluation three to 13 days after treatment were included in the analysis of results. All patients yielding N gonorrhoeae at follow up were considered to have failed treatment.
STATISTICAL ANALYSIS
We used Student's t test and the x2 test.
Results
From August 1982 to May 1983 we studied 472 men and women attending the Bangrak STD clinic with presumptive gonococcal infections. After obtaining informed written consent we treated 236 with spectinomycin and 236 with cefuroxime. The cultures obtained at the time of entry into the study were negative in 35 patients, and 72 other patients failed to return for follow up evaluation three to 13 days after treatment. Thus the final study population consisted of 365 patients who yielded positive cultures before treatment and returned for follow up.
The age, marital status, occupation, reasons for attending the clinic, recent sexual history, and examination findings of patients were similar in the two treatment groups but were different for men and women. Table I shows that 98% of the patients were cured, and cure rates did not vary according to the drug used for treatment, sex of the patient, or penicillinase test results.
More than 90% (329/365) of the patients were asymptomatic at follow up. Although dysuria or discharge, or both, were more common in men treated with cefuroxime (12% (22/181)) than with spectinomycin (6% (11/184)), these differences were not significant by x2 analysis. Only 14 patients (4%) gave a history of sexual intercourse between treatment and re-evaluation; three of these 14 patients were not cured.
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tTrimethoprim and sulphamethoxazole in a ratio of 1:19.
The pharmacokinetics of, and in vitro susceptibility of gonococci to, cefuroxime and the efficacy of the regimen suggest that doses of cefuroxime lower than we used would also cure more than 95% of infections. Serum cefuroxime concentrations were Injection pain was the only major side effect of cefuroxime noted in this study, but it was not disabling in any patient. Pain at the injection site is a problem generally encountered with the cephalosporins." Reconstitution with 0 5%o lignocaine has 310 A Chitwarakorn, C Ariyarit K Panikabutra, A Buateing, J Biddle, S Thompson, and S Brown reduced injection pain associated with other cephalosporins and may be useful for cefuroxime.
The high cure rates observed in this study deserve note. We believe that these were due to highly effective antibiotics and excellent patient compliance. Nearly 85% of the patients enrolled in the study returned for follow up examination within two weeks, and only 5% of these patients had had sexual re-exposure before the follow up visit. Many therapeutic studies have much lower follow up rates with higher re-exposure rates, both of which factors artificially reduce the reported cure rates.
Both kanamycin and thiamphenicol are used commonly in Thailand and other countries with a high prevalence of PPNG strains. We observed substantial in vitro resistance to these drugs, and failure rates of 501o for kanamycin and 12% for thiamphenicol have been seen in the Bangrak clinic.'7 Several cephalosporin regimens have been highly effective against infections with gonococci resistant to penicillin and have been recommended for regions with a high prevalence of PPNG strains.' The choice between several cephalosporins and spectinomycin is likely to be dictated by cost and availability. Currently in Bangkok, a I 5 g dose of cefuroxime costs 320 Baht (US $14-50), compared with 124 Baht for spectinomycin 2 g, 110 Baht for ceftriaxone 250 mg, 110 Baht for cefotaxime 500 mg, and 320 Baht for cefoxitin 2 g. As costs and availability are changing rapidly, these 1983 costs in Thailand may not apply generally.
Cefuroxime is an attractive, although expensive, therapeutic agent for gonococcal infections resistant to penicillin. It is a safe, well tolerated, single dose regimen that is highly effective. In addition, cefuroxime is active against experimental infection with syphilis,25 so this treatment for gonorrhoea would abort some incubating infections with Treponema pallidum. Patients often treat themselves in Thailand, however, which contributes to the selection of gonococcal strains resistant to penicillin; As cefuroxime and other new agents are introduced and become more widely used, it will be important to monitor patterns of susceptibility. Resistance to this and other cephalosporins may develop as the drugs are used more widely.
